Tolerance, autoimmunity, allogenicity

Слайд 2

Tolerance, Autoimmunity, Allogenicity (2nd part)
III- Autoimmunity A – AID classification and examples
B – animal

Tolerance, Autoimmunity, Allogenicity (2nd part) III- Autoimmunity A – AID classification and
models
C – Why do AID occur? D – Diagnosis, Treatments?
IV- Allogeneicity and transplantation tolerance
A – Concept and mechanism of Allogenicity and MLR
B – Classification & Mechanism of Graft rejection
C – GVHD
D – Biotherapies?

Слайд 3

III - Autoimmunity

III - Autoimmunity

Слайд 4

The causes of the disease outbreak are still unknown

7 % of

The causes of the disease outbreak are still unknown 7 % of
population (still increasing)

Characteristics: evolutive, progression by surges

, environment

Слайд 5

III- Autoimmunity A - AID classification and examples

III- Autoimmunity A - AID classification and examples

Слайд 6

Wikipedia 2011

Hypersensibility

? Complement lysis

? Ag-Ab accumulation

? T cell-mediated Autoimmunity

? Agonists or bloquing

Wikipedia 2011 Hypersensibility ? Complement lysis ? Ag-Ab accumulation ? T cell-mediated
Ab

T1D
Oophoritis
Prostatis

(lungs & Kidneys)

(RBCs)

(Platelets)

(Mother Abs cross Placenta)

Слайд 8

Type II-V :

affects up to 2% of the female population, sometimes appears

Type II-V : affects up to 2% of the female population, sometimes
after childbirth, Hereditary factors are the major risk factor for the development of Graves disease, with "79% of the liability to the development of GD ... attributable to genetic factors”. Smoking and exposure to second-hand smoke is associated with the eye manifestations but not the thyroid manifestations.

This leads to an enlargment of the thyroid and very high levels of circulating thyroid hormones

The hormonal dysregulation induces heartbeat, muscle weakness, disturbed sleep, and irritability.

Слайд 10

(Type II-V)

(Type II-V)

Слайд 14

Mark Anderson, MD, PHD UCSF Diabetes Center

Mark Anderson, MD, PHD UCSF Diabetes Center

Слайд 16

Production of autoantibodies

Production of autoantibodies